ClinicalTrials.Veeva

Menu

A Multicenter Study to Evaluate the ROX Coupler in Subjects With Hypertension (CONTROL HTN-2)

R

ROX Medical

Status

Terminated

Conditions

Hypertension
High Blood Pressure

Treatments

Other: Sham procedure
Device: ROX Coupler

Study type

Interventional

Funder types

Industry

Identifiers

NCT02895386
US HTN-01

Details and patient eligibility

About

To evaluate the safety and effectiveness of the ROX Coupler used to create an arteriovenous anastomosis in the iliac region (between the iliac artery and vein) in subjects with hypertension.

Enrollment

30 patients

Sex

All

Ages

22 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Mean 24-hour ambulatory blood pressure monitoring (ABPM) SBP ≥ 140 mmHg at screening.

Exclusion criteria

  • Any serious medical condition that may adversely affect the patient's safety, limit the subject's ability to participate in the study, comply with follow-up requirements or impact the scientific integrity of the study.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

30 participants in 2 patient groups

Treatment Group A
Active Comparator group
Description:
ROX Coupler implantation and continuing antihypertensive medications.
Treatment:
Device: ROX Coupler
Control Group B
Sham Comparator group
Description:
Sham procedure and continuing current antihypertensive medications.
Treatment:
Other: Sham procedure

Trial contacts and locations

13

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems